Vanceril Double Strength


Vanceril Double Strength

Drug - Vanceril Double Strength
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Beclomethasone Dipropionate
Multiple ingredients are in alphabetical order.

Strength - 0.084MG/INH
The potency of the active ingredient(s), Beclomethasone Dipropionate. May repeat for multiple part products.

Applicant - SCHERING
The firm name holding legal responsibility for Vanceril Double Strength. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020486
The FDA assigned number to Vanceril Double Strength. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Vanceril Double Strength. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 24, 1996
The date Vanceril Double Strength was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Vanceril Double Strength. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Vanceril Double Strength is in. Format is RX, OTC, DISCN.

Applicant Full Name - Schering Corp
The full name of the firm holding legal responsibility for the new application of Vanceril Double Strength.

Vanceril Double Strength